MAPT and Alzheimer disease: Amyloid-β peptide(Aβ), tau proteins, plasma proteins, or lipids have shown usefulness in AD diagnosis (19), and there is increasing research on novel biomarkers such as Aβ42/Aβ43 (20) and phosphorylated Tau at position 181(P-tau181).